Javascript must be enabled to continue!
Psychosocial particularities for adherence concept at chronic schizophrenia patients
View through CrossRef
BackgroundConcept of therapeutic adherence in schizophrenia describes the level of agreement between patient's medication taking and the psychiatrist expectations. The literature data reveal the facts that therapeutic adherence is low in the case of chronic evolution of schizophrenia. The sociological concept follows the notion of adherence to treatment for the schizophrenic patient in the patient-family-psychiatrist relation.MethodsTo find the level of understanding the concept of therapeutic adherence at the level of schizophrenic patients, their families and psychiatrists, we used a scale with 5 items. This scale was applied to a lot of 30 schizophrenic patients, 30 members of family or caregivers and 30 psychiatrists. The items referred to efficacy of pharmacological therapy, adverse effects of antipsychotics, administration form of antipsychotic (daily or long action), accessibility to medication, the direct relationship between patient and therapeutically team in the moment of taking medication.ResultsFor the patients: relationship between patient and psychiatrist, administration form and accessibility to medication.For the family: accessibility to medication, adverse effects, efficacy of therapy.For the psychiatrist: adverse effects, efficacy of therapy and accessibility to medication.DiscussionFor the patients the relation with therapeutically team is the most important element of adherence and is significant correlated with the long action antipsychotics therapy. The concept of adherence must be individualized depending to patient, family and psychiatrist. The results of this study can be a prerequisite for further research. Decrease of adherence to antipsychotics treatment suggests the switch to a long action antipsychotic.
Title: Psychosocial particularities for adherence concept at chronic schizophrenia patients
Description:
BackgroundConcept of therapeutic adherence in schizophrenia describes the level of agreement between patient's medication taking and the psychiatrist expectations.
The literature data reveal the facts that therapeutic adherence is low in the case of chronic evolution of schizophrenia.
The sociological concept follows the notion of adherence to treatment for the schizophrenic patient in the patient-family-psychiatrist relation.
MethodsTo find the level of understanding the concept of therapeutic adherence at the level of schizophrenic patients, their families and psychiatrists, we used a scale with 5 items.
This scale was applied to a lot of 30 schizophrenic patients, 30 members of family or caregivers and 30 psychiatrists.
The items referred to efficacy of pharmacological therapy, adverse effects of antipsychotics, administration form of antipsychotic (daily or long action), accessibility to medication, the direct relationship between patient and therapeutically team in the moment of taking medication.
ResultsFor the patients: relationship between patient and psychiatrist, administration form and accessibility to medication.
For the family: accessibility to medication, adverse effects, efficacy of therapy.
For the psychiatrist: adverse effects, efficacy of therapy and accessibility to medication.
DiscussionFor the patients the relation with therapeutically team is the most important element of adherence and is significant correlated with the long action antipsychotics therapy.
The concept of adherence must be individualized depending to patient, family and psychiatrist.
The results of this study can be a prerequisite for further research.
Decrease of adherence to antipsychotics treatment suggests the switch to a long action antipsychotic.
Related Results
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
Abstract
Background
Evidence shows that schizophrenia is associated with increased incidence of cardiovascular diseases (CVD), i...
M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
Abstract
Background
This study aims to investigate the perception of schizophrenia, knowledge level about schizophrenia, stigma,...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
From Birth to Belonging: Psychosocial Development in Early Childhood
From Birth to Belonging: Psychosocial Development in Early Childhood
The first years of life represent a crucial period in child development. While learning to walk and talk are well-known milestones, children also develop essential social and emoti...
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Abstract
Background
Patients with schizophrenia frequently encounter challenges related to sexuality and intimacy; however, the ...
EVALUATING PSYCHOSOCIAL SUPPORT AND TREATMENT ADHERENCE AMONG RURAL BREAST CANCER PATIENTS ATTENDING PUNJABI TERTIARY HOSPITALS
EVALUATING PSYCHOSOCIAL SUPPORT AND TREATMENT ADHERENCE AMONG RURAL BREAST CANCER PATIENTS ATTENDING PUNJABI TERTIARY HOSPITALS
Background: Breast cancer treatment adherence is critical for improving survival outcomes, yet rural patients often face significant barriers. Psychosocial support has been shown t...
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
Abstract
Background
The role of oral and gut microbiomes in the pathogenesis of schizophrenia has recently come to light with th...
Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
Background: Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major prob...

